Tim Henkel as executive vice president and head of R&D...Doug Gessl as chief operating officer and chief financial officer...and Lisa Wittmer as vice president of regulatory affairs

GenVec Inc., of Gaithersburg, Md., elected Adel A. F. Mahmoud and Edward M. Connor Jr...It also named Timothy D. Kasbe senior vice president and chief information officer...Medicure Inc., of Winnipeg, Manitoba, appointed Dawson Reimer president and chief operating officer

Ascletis Inc., of Research Triangle Park, N.C., and Hangzhou, China, appointed Allan Baxter chief strategy officer...Genesis Biopharma Inc., of Los Angeles, added David Voyticky and Merrill A. McPeak to its board and named Laszlo Radvanyi to its scientific and medical advisory board

The people who are assigned to the committee include Michael Conte, William Marston, Richard Powell and Michael Smith...Ablexis LLC, of San Francisco, appointed Jake Bauer senior director of corporate development and business operations...Agennix AG, of Planegg, Germany, appointed Jill Porter senior vice president of pharmaceutical development and appointed Christine Boisclair senior vice president of global regulatory affairs

Vivo Ventures LLC, of Palo Alto, Calif., promoted Chen Yu and James Zhao to managing partners...Xceleron Ltd., of York, UK, appointed David Roblin to its board and named Stuart Best senior director of operations...XOMA Ltd., of Berkeley, Calif., appointed Paul Rubin vice president and chief medical officer

It also named Patrick Hwu and Mario Sznol to its recently formed scientific and medical advisory board and named Martin Schroeder to its board

Co-founder Douglas P. Clark was named chief medical officer and acting CEO, effective July 1...Compass Biotechnologies Inc., of Edmonton, Alberta, appointed Joseph Sinkule president and chief operating officer...Cytochroma Inc., of Markham, Ontario, appointed Cynthia Lavoie and Osamu Otani to its board

An item in the May 19, 2011, edition of BioWorld Today's Appointments and Advancements column should have said that Adimab LLC appointed Frances Heller to its board

Addex Pharmaceuticals Ltd., of Geneva, added Hoyoung Huh and Oleg Nodelman to its board...Aileron Therapeutics Inc., of Cambridge, Mass., named Julian Adams, Scott Kapnick and John H. McArthur to its board, and named Stephen W. Fesik, Robert H. Grubbs and Michael Hanley to its scientific advisory board

Neoprobe Corp., of Dublin, Ohio, appointed Mark Pykett president and CEO...Regulus Therapeutics Inc., of La Jolla, Calif., named Lars Karlsson vice president of immunology and fibrosis...Tobira Therapeutics Inc., of Manalapan, N.J., named Andrew Hindman president and CEO

Concert Pharmaceuticals Inc., of Lexington, Mass., appointed Mark Roessel vice president of regulatory affairs and quality assurance and named LuAnn Sabounjian vice president of clinical operations...Infinity Pharmaceuticals Inc., of Cambridge, Mass., appointed Joshua D. Hamermesh vice president of business and corporate development...Lightlake Therapeutics Inc., of London, appointed Cynthia McCormick as senior clinical and regulatory advisor

Access Pharmaceuticals Inc., of Dallas, named Anthony Mottola vice president of managed care and market access...Actelion Ltd., of Allschwil, Switzerland, nominated Jean-Pierre Garnier and Robert Bertolini to its board...Ampio Pharmaceuticals Inc., of Greenwood Village, Colo., appointed Mark D. McGregor chief financial officer and corporate secretary

Hospira Inc., of Lake Forest, Ill., elected F. Michael (Mike) Ball CEO and board member...ITherX Pharmaceuticals Inc., of San Diego, named Stefan Zeuzem chairman of its scientific and clinical advisory board

Pearl Therapeutics Inc., of Redwood City, Calif., appointed Chuck Bramlage president and CEO...Plethora Solutions Holdings plc, of London, appointed Richard Horsman to its board and named Billy Hargan vice president of commercial operations...Protox Therapeutics Inc., of Vancouver, British Columbia, named William Rohn and Arnit Sobti to its board

ATyr Pharma, of San Diego, formed a therapeutic advisory board comprising Thomas O. Daniel, L. Patrick Gage, Rich Heyman, Keith James, Paul Negulescu, Timothy Rink, Wendell Wierenga and Doug Williams...Otonomy Inc., of San Diego, appointed G. Michael Wall vice president of product development and named Cindy Berejikian vice president of program management

BioNanomatrix Inc., of Philadelphia, named R. Erik Holmlin president, CEO and director...It also added Michael Handelman as chief financial officer, treasurer and secretary...Medgenics Inc., of Misgav, Israel, added Isaac Blech and Raymond Dean Hautamaki to its board

Oncos Therapeutics, of Helsinki, Finland, appointed Jonathan Knowles and Robert Burns to its board...Soligenix Inc., of Princeton, N.J., appointed Kevin Horgan senior vice president and chief medical officer...Topaz Pharmaceuticals Inc., of Horsham, Pa., appointed Mark Strobeck vice president and chief business officer

executive vice president and chief operating officer and named John A. Bellano senior vice president of sales and commercial programs

Markus Leyck Dieken senior vice president and general manager, Germany...and Manuela Maronati vice president, sales and marketing, Europe